You are here

Genentech

Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech

Fierce Biotech

Tue, 08/6/24 - 11:34 am

Sangamo Therapeutics

neurodegenerative disease

Peloton’s Robin Arzón shines light on MS at Genentech-backed panel

Medical Marketing and Media

Fri, 08/2/24 - 11:41 am

pharma marketing

multiple sclerosis

Novartis, Roche unit and others face Italy antitrust probe over eye drug

Reuters

Thu, 06/6/24 - 11:34 am

Samsung Bioepis

Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate

BioSpace

Thu, 05/16/24 - 11:40 am

clinical trials

Big Pharma’s most improved drugs: a new generation of blockbusters

Pharma Voice

Tue, 05/14/24 - 11:34 am

Genentech experts call for multiple strategies to diversify clinical trials

Clinical Trials Arena

Thu, 05/2/24 - 10:08 pm

clinical trials

clinical trial diversity

Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds

BioSpace

Wed, 04/24/24 - 09:55 am

Roche, Adaptimmune part ways on cell therapy research

BioPharma Dive

Sun, 04/14/24 - 01:26 pm

Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff

BioSpace

Thu, 04/11/24 - 10:22 pm

Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval

BioSpace

Sun, 03/10/24 - 08:25 pm

Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

Fierce Biotech

Tue, 01/23/24 - 10:43 am

drug development

autoimmune disease

Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech

Fierce Biotech

Mon, 01/22/24 - 11:19 am

Alzheimer's diseasse

Genentech confirms Magargee as permanent CEO

Pharmaphorum

Wed, 12/13/23 - 10:09 pm

Ashley Magargee

Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients

Fierce Biotech

Mon, 12/4/23 - 06:14 pm

multiple sclerosis

clinical trials

Roche’s Genentech partners with Nvidia in AI drug deal

BioPharma Dive

Tue, 11/21/23 - 12:00 pm

artificial intelligence

A year after Roche's Alzheimer's failure, scientists reflect on what could have been

Fierce Biotech

Wed, 11/15/23 - 11:49 pm

Alzheimer's disease

BioMarin’s longtime CEO Jean-Jacques Bienaimé hands the reins to Genentech’s Alexander Hardy

Fierce Pharma

Wed, 11/1/23 - 10:20 pm

Jean-Jacques Bienaimé

Alexander Hardy

FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

BioSpace

Fri, 10/27/23 - 11:34 am

retinal vein occlusion

Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer

BioSpace

Wed, 10/18/23 - 10:17 am

non-small cell lung cancer

Pages